Alembic Settles With Vanda Over Schizophrenia Drug Generic
Vanda Pharmaceuticals and Alembic Pharmaceuticals notified a Delaware federal judge Friday that they have settled a patent dispute over Alembic's planned generic version of Vanda's schizophrenia drug Fanapt....To view the full article, register now.
Already a subscriber? Click here to view full article